BENTSUR RON bought NVCT
November 5, 2025 · Form 4 insider transaction
BENTSUR RON bought 5,000 shares of Nuvectis Pharma, Inc. at $5.72 per share, a transaction worth $28.6K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
5,000
Price
$5.72
Total value
$28.6K
InsiderBENTSUR RON
Role—
CompanyNuvectis Pharma, Inc. (NVCT)
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateNovember 5, 2025
Filing dateNovember 6, 2025
Shares owned after3,525,924
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Includes 676,759 shares of restricted stock.